Worldwide Anti-rheumatics Market to 2025 – Featuring Biogen, Celltrion & Amgen Among Others – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Anti-rheumatics Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025” report has been added to ResearchAndMarkets.com’s offering.

The report on the global anti-rheumatics market provides qualitative and quantitative analysis for the period from 2017 to 2025. The report predicts the global anti-rheumatics market to grow with a CAGR of 9.5% over the forecast period from 2019-2025. The study on anti-rheumatics market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2017 to 2025.

The report on anti-rheumatics market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global anti-rheumatics market over the period of 2017 to 2025. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter’s five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global anti-rheumatics market over the period of 2017 to 2025. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

What does this report deliver?

1. Comprehensive analysis of the global as well as regional markets of the anti-rheumatics market.
2. Complete coverage of all the segments in the anti-rheumatics market to analyze the trends, developments in the global market and forecast of market size up to 2025.
3. Comprehensive analysis of the companies operating in the global anti-rheumatics market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
   

Market Dynamics

Drivers

• Rising prevalence of rheumatoid arthritis, increase in geriatric population and increasing novel therapeutics
• Rising healthcare awareness, increase in disposable income and availability of various treatments for inflammatory arthritides

Restraints

• Many side effects associated with therapy and medication

Opportunities

• Technological advancement for new drug development and favorable government support

Companies Profiled

• Pfizer, Inc.
• Johnson & Johnsons
• Bristol-Myers Squibb Company
• F. Hoffmann-La Roche Ltd.
• Celegene Corporations
• MedImmune, LLC
• Takeda Pharmaceutical Company Ltd.
• Biogen Inc.
• Celltrion Inc.
• Amgen Inc.

For more information about this report visit https://www.researchandmarkets.com/r/6ot3ff

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900